Physician profile
David L Stone
NPI 1972918431
$1,831.31
in general payments reported to CMS, 2019-2025
18 companies · $228 in 2025
The $228 reported for 2025 was less than what a typical Vascular Neurology provider received nationally (typical 2025 total: $360).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $36.13 · 2020: $68.47 · 2021: $131 · 2022: $241 · 2023: $362 · 2024: $765 · 2025: $228.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,355.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,355.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $456.19 | 2024-2025 | Penumbra System |
| Ge Healthcare | $321.17 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $236.15 | 2023-2024 | Andexxa |
| Microtransponder, INC. | $190.31 | 2024 | |
| Boston Scientific Corporation | $140.40 | 2024 | Watchman Access System |
| Alexion Pharmaceuticals, INC. | $129.16 | 2021-2023 | Ultomiris |
| Medtronic, INC. | $55.21 | 2023 | Solitaire X |
| Sunovion Pharmaceuticals INC. | $53.22 | 2020-2021 | |
| Horizon Therapeutics Plc | $46.22 | 2022-2023 | Uplizna |
| Acadia Pharmaceuticals INC | $39.85 | 2019-2020 | |
| Akcea Therapeutics, INC. | $29.39 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $26.21 | 2021 | |
| Sk Life Science, INC. | $23.38 | 2021 | |
| Allergan, INC. | $20.96 | 2022 | |
| Nevro Corp. | $19.04 | 2023 | Senza |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $16.92 | 2019 | |
| Amylyx Pharmaceuticals, INC. | $16.32 | 2023 | Relyvrio |
| Teva Pharmaceuticals USA, INC. | $11.21 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Stone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.